Formularies Should Stress Rx Compliance, Not Co-Pays, Pitney Bowes Says
Executive Summary
Covering chronic disease medications as tier one to encourage patient compliance can help manage health care costs, Pitney Bowes Manager-Employee Benefits Design & Development Christine Berman said
You may also be interested in...
GSK Wellbutrin Metabolite, Advair Successor In Phase II; NDAs In 2006-2008
GlaxoSmithKline expects to bring a Wellbutrin (bupropion) metabolite into Phase III studies for major depressive disorder during the second half of 2004
Allegra “Drives On” With Physician Campaign Ahead Of Claritin OTC Switch
Aventis will not change its marketing strategy for Allegra following the departure of Schering-Plough's Claritin from the prescription antihistamine market
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011